John Furey - Jul 2, 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Director
Signature
John Furey, by /s/ Peter N. Efremenko, Attorney-In-Fact
Stock symbol
PCVX
Transactions as of
Jul 2, 2024
Transactions value $
$0
Form type
4
Date filed
7/3/2024, 06:12 PM
Previous filing
Jul 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Award $0 +16.8K $0.00 16.8K Jul 2, 2024 Common Stock 16.8K $76.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option shall vest over 36 months, 1/3 of which will vest on July 2, 2025 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.